| Pulse Biosciences, Inc Common Stock (DE) | $3.9b | $54.86 | +3.5% | 332.2K | |
| Arbutus Biopharma Corporation Common Stock | $1.0b | $5.12 | -0.1% | 2.6M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $98.4m | $0.85 | +0.5% | 325.7K | |
| Zentek Ltd. Common Stock | $85.3m | $0.49 | 0.0% | N/A | |
| Clene Inc. Common Stock | $53.4m | $3.33 | -5.2% | 112.9K | |
| NanoViricides Inc. | $29.4m | $1.07 | +4.9% | 500.9K | |
| Polyrizon Ltd. Ordinary Shares | $26.2m | $11.03 | -0.2% | 66.7K | |
| Lexaria Bioscience Corp. Common Stock | $21.8m | $3.42 | -17.9% | 163.3K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $12.9m | $8.88 | -0.2% | 13.2K | |
| TransCode Therapeutics, Inc. Common Stock | $2.3m | $1.69 | 0.0% | 13.5K |